Novo Nordisk faces scrutiny over UK pharmacy sponsorships tied to weight-loss drugs, with critics citing conflicts of interest and regulatory breaches.
6h
India Today on MSNRetatrutide outperforms Ozempic in weight loss, new study findsExperimental weight-loss drug Retatrutide shows promise, helping obese adults lose up to 22% of their weight in 48 weeks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results